Case-Control Study to Investigate the Association Between Serum Apolipoprotein B/A1 Ratio and Atrial Fibrillation by Sex in 920 Patients from China

14 May 2022 : Clinical Research

Xia Zhong^1ACE, Huachen Jiao^2DFG*, Dongsheng Zhao^1BC, Jing Teng^1AF, Mengqi Yang

^1BE

DOI: 10.12659/MSM.936425

Med Sci Monit 2022; 28:e936425

Background Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Table 4 Differences in serum APOB/APOA1 ratio by different subtypes, complications, and statins use in patients with atrial fibrillation.

Variable	n	APOB/APOA1 ratio	P value
Subtypes of AF
Paroxysmal AF	320	0.78±0.58	0.082
Permanent AF	600	0.72±0.28	0.082
Complications of AF
AF+hypertension	618	0.74±0.47	0.296
AF+CHD	812	0.74±0.43
AF+diabetes	274	0.79±0.65
Whether or not statins were used
Yes	605	0.73±0.46	0.421
No	315	0.75±0.29	0.421
Data are presented as mean±SD. AF – atrial fibrillation; APOA1 – apolipoprotein A1; APOB – apolipoprotein B; CHD – coronary heart disease.

Back to the Article